News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) With Experts In Chronic Pain


5/27/2014 6:18:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MELBOURNE, Australia, May 27, 2014 /PRNewswire via COMTEX/ -- MELBOURNE, Australia, May 27, 2014 /PRNewswire/ --

Expanded SAB will oversee development of EMA401, Company's lead program for treating chronic pain

Spinifex Pharmaceuticals, a pain drug development company, today announces that three internationally acclaimed scientists in chronic pain research have joined the Company's Scientific Advisory Board (SAB).

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES